These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18336224)

  • 1. Proteomics: technologies for protein analysis.
    Gomase VS; Kale KV; Tagore S; Hatture SR
    Curr Drug Metab; 2008 Mar; 9(3):213-20. PubMed ID: 18336224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic technologies for cancer target validation.
    Jain KK
    Drug Discov Today Technol; 2004 Oct; 1(2):75-8. PubMed ID: 24981374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics technologies for the global identification and quantification of proteins.
    Brewis IA; Brennan P
    Adv Protein Chem Struct Biol; 2010; 80():1-44. PubMed ID: 21109216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics as a Tool to Study Molecular Changes During Plant Morphogenesis In Vitro.
    Wendt Dos Santos AL; Souza Reis R; Schuabb Heringer A; Segal Floh EI; Santa-Catarina C; Silveira V
    Methods Mol Biol; 2018; 1815():339-349. PubMed ID: 29981134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and islet research.
    Ahmed M
    Adv Exp Med Biol; 2010; 654():363-90. PubMed ID: 20217506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis.
    Vercauteren FG; Arckens L; Quirion R
    Amino Acids; 2007 Sep; 33(3):405-14. PubMed ID: 17136510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mass spectrometry data in proteomics.
    Matthiesen R; Jensen ON
    Methods Mol Biol; 2008; 453():105-22. PubMed ID: 18712299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomics.
    Arthur JM
    Curr Opin Nephrol Hypertens; 2003 Jul; 12(4):423-30. PubMed ID: 12815339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in plant proteomics.
    Chen S; Harmon AC
    Proteomics; 2006 Oct; 6(20):5504-16. PubMed ID: 16972296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global and targeted quantitative proteomics for biomarker discovery.
    Veenstra TD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical proteomics for cancer biomarker discovery and therapeutic targeting.
    Krieg RC; Paweletz CP; Liotta LA; Petricoin EF
    Technol Cancer Res Treat; 2002 Aug; 1(4):263-72. PubMed ID: 12625785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic technologies in modern biomedical science.
    Govorun VM; Archakov AI
    Biochemistry (Mosc); 2002 Oct; 67(10):1109-23. PubMed ID: 12460109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent developments in proteome informatics for mass spectrometry analysis.
    Wright JC; Hubbard SJ
    Comb Chem High Throughput Screen; 2009 Feb; 12(2):194-202. PubMed ID: 19199887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic technology and its biomedical applications.
    Lau AT; He QY; Chiu JF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of proteomic technologies to cytologic specimens. A review.
    Angeletti C
    Acta Cytol; 2003; 47(4):535-44. PubMed ID: 12920743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining bioinformatics and MS-based proteomics: clinical implications.
    Acosta-Martin AE; Lane L
    Expert Rev Proteomics; 2014 Jun; 11(3):269-84. PubMed ID: 24720436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics approaches for myeloid leukemia drug discovery.
    Kapoor I; Pal P; Lochab S; Kanaujiya JK; Trivedi AK
    Expert Opin Drug Discov; 2012 Dec; 7(12):1165-75. PubMed ID: 22971110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics: bases for protein complexity understanding.
    Rotilio D; Della Corte A; D'Imperio M; Coletta W; Marcone S; Silvestri C; Giordano L; Di Michele M; Donati MB
    Thromb Res; 2012 Mar; 129(3):257-62. PubMed ID: 22283976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.